发明名称 TAIL VARIANT OF OXIDATION-REDUCTION ACTIVITY THERAPEUTIC AGENT FOR THERAPY OF MITOCHONDRIAL DISEASE AND RELATED CONDITION AND FOR ADJUSTMENT OF ENERGY BIOMARKER
摘要 PROBLEM TO BE SOLVED: To provide a compound useful for therapy or suppression of diseases due to mitochondrial diseases and for adjustment of an energy biomarker in a subject.SOLUTION: A method of treating a mitochondrial disease, adjusting 1 or more energy biomarkers, normalizing 1 or more energy biomarkers, or enhancing 1 or more energy biomarkers comprises a step of administering a therapeutically effective amount of a hydroquinone compound represented by the formula or an oxidized form thereof (a quinone compound) to a subject (Rto Rare each independently a C1 to 4 alkyl or the like; and Ris a C1 to 20 alkyl, alkenyl or the like.)
申请公布号 JP2015078224(A) 申请公布日期 2015.04.23
申请号 JP20140254928 申请日期 2014.12.17
申请人 EDISON PHARMACEUTICALS INC 发明人 MILLER GUY M;HECHT SIDNEY M
分类号 A61K31/05;A61K31/122;A61P3/10;A61P9/00;A61P15/12;A61P21/02;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P27/02;A61P35/00;A61P43/00;C07C39/08;C07C50/02;C07C50/06 主分类号 A61K31/05
代理机构 代理人
主权项
地址